|
|
Name: |
Kynam Capital Management LP |
City: |
PRINCETON |
State: |
NJ |
Zip: |
08540 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
30 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
NTRA |
Natera, Inc. |
1 |
- |
$91.66 |
$150,336,000 |
2,400,000 |
17.01% |
17,424,000 |
-603,668 |
2.201 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
2 |
- |
$21.06 |
$122,313,000 |
5,660,000 |
13.84% |
70,041,000 |
2,060,000 |
7.373 |
N/A |
|
CLDX |
Celldex Therapeutics Inc |
3 |
- |
$36.30 |
$119,214,000 |
3,005,904 |
13.49% |
31,150,000 |
-194,096 |
5.741 |
Diagnostic Substances |
|
PCVX |
Vaxcyte, Inc. |
4 |
- |
$0.00 |
$62,951,000 |
1,002,407 |
7.12% |
-3,446,000 |
-300,000 |
0.929 |
N/A |
|
VERA |
Vera Therapeutics, Inc. |
5 |
- |
$0.00 |
$56,142,000 |
3,650,339 |
6.35% |
15,615,000 |
694,286 |
8.62 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
6 |
- |
$25.15 |
$45,972,000 |
2,004,875 |
5.2% |
15,637,000 |
186,218 |
3.567 |
N/A |
|
IMGN |
Immunogen Inc |
7 |
New |
$31.23 |
$42,177,000 |
1,422,503 |
4.77% |
42,177,000 |
1,422,503 |
0.644 |
Drug Manufacturers - ... |
|
MOR |
Morphosys Ag |
8 |
New |
$18.04 |
$41,923,000 |
4,234,685 |
4.74% |
41,923,000 |
4,234,685 |
3.234 |
N/A |
|
COGT |
Cogent Biosciences, Inc. |
9 |
- |
$6.02 |
$34,426,000 |
5,854,766 |
3.9% |
12,877,000 |
3,644,641 |
7.404 |
N/A |
|
LQDA |
Liquidia Technologies Inc |
10 |
- |
$12.53 |
$32,461,000 |
2,698,324 |
3.67% |
19,781,000 |
698,324 |
7.148 |
N/A |
|
BCRX |
Biocryst Pharmaceuticals Inc |
11 |
- |
$4.16 |
$27,554,000 |
4,600,000 |
3.12% |
5,371,000 |
1,466,807 |
2.605 |
Biotechnology |
|
TSVT |
2seventy Bio, Inc. |
12 |
- |
$0.00 |
$25,423,000 |
5,953,825 |
2.88% |
2,084,000 |
0 |
11.458 |
N/A |
|
DVAX |
Dynavax Technologies Corp |
13 |
- |
$11.21 |
$21,171,000 |
1,514,383 |
2.4% |
13,786,000 |
1,014,383 |
1.124 |
Drug Manufacturers - ... |
|
WVE |
Wave Life Sciences Ltd. |
14 |
- |
$4.66 |
$19,857,000 |
3,932,082 |
2.25% |
-2,752,000 |
0 |
4.529 |
N/A |
|
TVTX |
Travere Therapeutics, Inc |
15 |
- |
$5.26 |
$17,980,000 |
2,000,000 |
2.03% |
9,420,000 |
1,042,498 |
2.283 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
16 |
- |
$12.88 |
$13,240,000 |
607,915 |
1.5% |
2,507,000 |
-91,766 |
1.341 |
N/A |
|
AMRN |
Amarin Corp Plc |
17 |
- |
$0.87 |
$10,460,000 |
12,022,957 |
1.18% |
-601,000 |
0 |
3.073 |
Drug Manufacturers - ... |
|
SLRN |
Acelyrin, Inc. |
18 |
- |
$4.24 |
$8,952,000 |
1,200,000 |
1.01% |
-3,252,000 |
0 |
1.235 |
N/A |
|
STRO |
Sutro Biopharma Inc |
19 |
- |
$3.42 |
$8,587,000 |
2,001,727 |
0.97% |
3,199,000 |
449,052 |
3.556 |
N/A |
|
BNR |
Burning Rock Biotech Ltd |
20 |
- |
$0.00 |
$8,086,000 |
8,694,426 |
0.92% |
-159,000 |
194,426 |
8.542 |
N/A |
|
CRBU |
Caribou Biosciences, Inc. |
21 |
- |
$3.71 |
$6,123,000 |
1,068,527 |
0.69% |
1,015,000 |
0 |
1.782 |
N/A |
|
TYRA |
Tyra Biosciences, Inc. |
22 |
New |
$0.00 |
$4,712,000 |
340,190 |
0.53% |
4,712,000 |
340,190 |
0.824 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
23 |
- |
$0.00 |
$3,524,000 |
442,704 |
0.4% |
-1,202,000 |
-287,768 |
0.506 |
N/A |
|
GOSS |
Gossamer Bio Inc |
30 |
Closed |
$0.67 |
$0 |
0 |
0% |
-208,000 |
-250,000 |
0 |
N/A |
|
PBYI |
Puma Biotechnology Inc |
29 |
Closed |
$5.02 |
$0 |
0 |
0% |
-1,247,000 |
-473,975 |
0 |
N/A |
|
NGNE |
Neurogene |
25 |
Closed |
$3.68 |
$0 |
0 |
0% |
-95,000 |
-24,037 |
0 |
N/A |
|
CNTB |
Connect Biopharma Holdings Adr |
28 |
Closed |
$1.34 |
$0 |
0 |
0% |
-434,000 |
-535,005 |
0 |
N/A |
|
GYRE |
Gyre Therapeutics |
27 |
Closed |
$0.51 |
$0 |
0 |
0% |
-43,000 |
-90,058 |
0 |
Biotechnology |
|
TSHA |
Taysha Gene Therapies, Inc. |
24 |
Closed |
$0.00 |
$0 |
0 |
0% |
-10,369,000 |
-3,281,313 |
0 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
26 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,904,000 |
-235,176 |
0 |
N/A |
|